Using the NCDB, the authors evaluated outcomes for patients with T4a esophageal adenocarcinoma. Receipt of surgery, compared to definitive chemoradiotherapy, offered a significant benefit to overall survival (HR 0.26).
You are here:
Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis
Submitted by: Emily Robinson
Source: The Annals of Thoracic Surgery
Source URL: https://doi.org/10.1016/j.athoracsur.2019.05.091
Keywords:
Author(s): Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, Norma E. Farrow, Shi-Fu J. Yang, Thomas A D’Amico, David H. Harpole Jr.
